FGF23 and its role in X-linked hypophosphatemia-related morbidity-Reference-Cited by-同舟云学术

FGF23 and its role in X-linked hypophosphatemia-related morbidity

Published:2019-02-26 Issue:1 Volume:14 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Beck-Nielsen Signe Sparre,Mughal Zulf,Haffner Dieter,Nilsson Ola,Levtchenko Elena,Ariceta Gema,de Lucas Collantes Carmen,Schnabel Dirk,Jandhyala Ravi^ORCID,Mäkitie Outi

Funder

Kyowa Kirin Services Ltd

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-019-1014-8.pdf

Reference251 articles.

1. Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol. 2009;160:491–7.

2. Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP. X-Linked Hypophosphatemia: A Clinical, Biochemical, and Histopathologic Assessment of Morbidity in Adults. Medicine (Baltimore). 1989;68:336.

3. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26:1381–8.

4. Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, Murshed M, et al. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia. J Bone Min Res. 2013;28:688–99.

5. Liu S, Guo R, Simpson LG, Xiao Z-S, Burnham CE, Quarles LD. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem. 2003;278:37419–26.

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine fibroblast growth factors in domestic animals;Domestic Animal Endocrinology;2024-10

2. Meta-analysis and systematic review: burosumab as a promising treatment for children with X-linked hypophosphatemia;Frontiers in Endocrinology;2024-08-15

3. Supplements in Rare Bone Diseases;Osteologie;2024-08

4. Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets;European Journal of Medical Genetics;2024-08

5. X-linked hypophosphataemia;The Lancet;2024-08